Kang, S., Yang, S., Jia, Y., Zhao, S. (2026). Cost-effectiveness of sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer in China. PLoS ONE. https://doi.org/10.1371/journal.pone.0343330